Latest filing published 11 Jun 2024 for Deciphera Pharmaceuticals, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jama Pitman discloses dealings in Deciphera Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 15 December 2021 to 11 June 2024, the count stands at 12 filings.
On the market, this insider has only sold: 5 sales, €92k in total. The rest of the record consists of 7 share grants. 2024 to date brings no purchases and 1 sale.
The latest filing, published on 11 June 2024, reports a share grant in Deciphera Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations